Shopping Cart 0
Cart Subtotal
AED 0

Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Lannett Company Inc (LCI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells its pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Company Inc Key Recent Developments

Aug 20,2018: Lannett announces preliminary fiscal 2018 fourth-quarter and full-year financial results

Aug 03,2018: Lannett Enters Licensing Agreement For Generic Concerta, Methylphenidate Hydrochloride ER Tablets

Jul 23,2018: Lannett Announces Multiple Product Launches

Jun 29,2018: Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary

May 07,2018: Lannett Acquires Portfolio Of Generic Products From Endo International

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Lannett Company Inc-Key Facts 5

Lannett Company Inc-Key Employees 6

Lannett Company Inc-Key Employee Biographies 7

Lannett Company Inc-Major Products and Services 8

Lannett Company Inc-History 10

Lannett Company Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

Lannett Company Inc-Business Description 15

Lannett Company Inc-Corporate Strategy 16

Lannett Company Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Lannett Company Inc-Strengths 17

Lannett Company Inc-Weaknesses 18

Lannett Company Inc-Opportunities 19

Lannett Company Inc-Threats 20

Lannett Company Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Lannett Company Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Aug 20, 2018: Lannett announces preliminary fiscal 2018 fourth-quarter and full-year financial results 32

Aug 03, 2018: Lannett Enters Licensing Agreement For Generic Concerta, Methylphenidate Hydrochloride ER Tablets 33

Jul 23, 2018: Lannett Announces Multiple Product Launches 34

Jun 29, 2018: Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary 35

May 07, 2018: Lannett Announces Fiscal 2018 Third-Quarter Financial Results 36

Apr 30, 2018: Lannett Announces Changes To Board Of Directors 37

Apr 20, 2018: Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer 38

Mar 12, 2018: Lannett Adds New Revenue Streams, Announces Agreements With Three Strategic Alliance Partners 39

Feb 07, 2018: Lannett Announces Fiscal 2018 Second-Quarter Financial Results; Reports Record Revenues, Strong Earnings 40

Feb 01, 2018: Lannett Enters Into Consulting Agreement With Former CEO, Arthur Bedrosian 41

Section 6-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Lannett Company Inc, Performance Chart (2014-2018) 26

Lannett Company Inc, Ratio Charts 28

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List Of Table

List of Tables

Lannett Company Inc, Key Facts 5

Lannett Company Inc, Key Employees 6

Lannett Company Inc, Key Employee Biographies 7

Lannett Company Inc, Major Products and Services 8

Lannett Company Inc, History 10

Lannett Company Inc, Other Locations 13

Lannett Company Inc, Subsidiaries 13

Lannett Company Inc, Key Competitors 21

Lannett Company Inc, Ratios based on current share price 22

Lannett Company Inc, Annual Ratios 23

Lannett Company Inc, Annual Ratios (Cont...1) 24

Lannett Company Inc, Annual Ratios (Cont...2) 25

Lannett Company Inc, Interim Ratios 27

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Lannett Company Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Lannett Company Inc, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Lannett Company Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sandoz Inc

Par Pharmaceutical Holdings Inc

Mylan Delaware Inc.

Mallinckrodt LLC

GlaxoSmithKline Plc

Dr. Reddy's Laboratories Inc